Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pristiq in chronic depression
NCT01537068Phase 4Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Feb 2012
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of desvenlafaxine in persistent depressive disorder (PDD), sponsored by New York State Psychiatric Institute. Started Feb 2012; status: completed.
02
Drugs
desvenlafaxine
03
Conditions
persistent depressive disorder (PDD)
Beyond the preview
Go deeper on NCT01537068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01537068.